Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what assessment he has made of the impact of the removal of domestic covid-19 restrictions on the health and wellbeing of clinically vulnerable and immunocompromised people.

No specific assessment has been made. However, we have made antiviral and other therapeutic treatments available for the most vulnerable patients and a targeted vaccination programme. On 1 April 2022, we issued updated guidance for those most at risk from serious illness as a result of COVID-19 infection, including those previously considered as clinically extremely vulnerable and the immunocompromised. We are also continuing to engage with patients and relevant stakeholder groups to review the impact of these measures.